FSL-1 Pre-Administration Protects Radiation-Induced Hematopoietic Organs Through the Modulation of the TLR Signaling Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115303 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Venkateshwara Rao Dronamraju und 4 weiteren Autor:innen. Beteiligte Einrichtung: Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, USA. Hauptthemen laut MEDLINE: Signal Transduction, Radiation-Protective Agents, Toll-Like Receptors, Radiation Injuries, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFRRI Intramural funding.
Abstract (Originalsprache)
Substantial progress has been made in the development of radiation countermeasures, resulting in the recent approval of several mitigators; however, there has yet to be an approved prophylactic radioprotectant. Research on countermeasure performance in mixed neutron and gamma radiation fields has also been scarce. Fibroblast-stimulating lipopeptide (FSL-1) is a novel synthetic agonist for toll-like receptor 2/6. In previous studies, the administration of FSL-1 before and after gamma radiation significantly improved survival outcomes for mice through the activation of the NF-κB pathway. In the current study, we tested FSL-1’s radioprotective abilities in a mixed radiation field that models one produced by a nuclear detonation in 11–14-week-old C57BL/6 male and female mice. We demonstrate that a single dose of 1.5 mg/kg of FSL-1 administered 12 h prior to 65% neutron 35% gamma mixed-field (MF) irradiation enhances survival, accelerates recovery of hematopoietic cell and stem cell populations, reduces inflammation, and protects innate immune function in mice. FSL-1’s ability to recover blood and protect immune functions is important in countering the high rate of incidence of sepsis caused by MF radiation’s damaging effects. These results demonstrate that FSL-1 is a promising prophylactic countermeasure where exposure to MF radiation is anticipated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, USA.
ORCID-Profile: Vidya P Kumar, Sanchita P Ghosh
Förderung
- AFRRI Intramural funding
Zitieren
APA
Dronamraju, V. R., Holmes-Hampton, G. P., Gu, E., Kumar, V. P., & Ghosh, S. P. (2025). FSL-1 Pre-Administration Protects Radiation-Induced Hematopoietic Organs Through the Modulation of the TLR Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115303
Vancouver
Dronamraju VR, Holmes-Hampton GP, Gu E, Kumar VP, Ghosh SP. FSL-1 Pre-Administration Protects Radiation-Induced Hematopoietic Organs Through the Modulation of the TLR Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115303
BibTeX
@article{Dronamraju2025,
author = {Dronamraju, Venkateshwara Rao and Holmes-Hampton, Gregory P and Gu, Emily and Kumar, Vidya P and Ghosh, Sanchita P},
title = {FSL-1 Pre-Administration Protects Radiation-Induced Hematopoietic Organs Through the Modulation of the TLR Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115303}
}
EUVIMED